The Journal of Clinical Endocrinology & Metabolism · 1965 · 19 citations · 0 references
Life SciencesBiochemistryEndocrinologyHormone BiochemistryReproductive EndocrinologySteroid BiochemistryAdrenal DisordersAdrenal HormonesAdrenal Steroid HormonesSodium HomeostasisSteroid Hormone BiochemistrySteroid MetabolismAbscess Formation PathophysiologyDisorders Of Adrenal SteroidogenesisPotency ComparisonRenal Sodium BalanceRenal Sodium RetentionSteroid Hormone ActionSteroidogenic DefectsUrinary Sodium Excretion
ACTH did not significantly affect serum sodium concentration or body weight in 6 patients with the sodium-losing form of congenital adrenal hyperplasia; it produced minimal increases in urinary sodium. There is no conclusive evidence that a sodium-losing steroid is secreted in this syndrome. 3α,16α-Dihydroxy-5β-pregnane-20-one caused delayed sterile abscess formation but no systemic fever. 3α,16α-Dihydroxy-5β-pregnane-20-one, 3β,16α-dihydroxy-Δ5-pregnene-20-one and 16α-hydroxy progesterone were tested for renal sodium-losing potency in man. Progesterone was also given as a standard for comparison. Progesterone had weak sodium-losing potency, 16α-hydroxy progesterone had minimal potency and the other 2 steroids had none. There is no known potent naturally occurring sodium-losing steroid.